No Data
We're Not Very Worried About ProKidney's (NASDAQ:PROK) Cash Burn Rate
ProKidney to Present Cell Therapy Data for CKD at ASN Kidney Week 2024
ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024
ProKidney to Participate in the UBS Virtual Organ Restoration Day
J.P. Morgan Initiates ProKidney(PROK.US) With Hold Rating
Maintaining Hold on ProKidney: Balancing Potential Against Need for Further Efficacy Data